Articles tagged "Risk factors"

2019 American Transplant Congress
Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)
A. Gruessner, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
2019 American Transplant Congress
Hope Act Donors With Organs Recovered For Transplant: The First Two Years
W. A. Werbel, O. Kusemiju, B. Barnaba, M. Bowring, B. Doby, C. Kirby, R. Fernandez, Y. Eby, J. Miller, D. Brown, S. Seaman, D. Ostrander, A. Tobian, D. Segev, C. M. Durand
Johns Hopkins University, Baltimore, MD
*Purpose: The HOPE Act expands the potential deceased donor pool to include HIV+ donors (HIV D+) and donors with false-positive (FP) HIV screens. The objective…
2019 American Transplant Congress
Factors Associated with Cardiovascular Subclinical Target Organ Damage in Liver Transplant Recipients
C. Kuepper¹, N. Memaran¹, B. Borchert¹, A. von Wick¹, E. Bauer¹, E. Jäckel², S. Ziegert², B. M. Schmidt³, A. Melk¹
¹Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany, ²Department of Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany, ³Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
*Purpose: Liver transplantation (LT) patients are prone to cardiovascular (CV) morbidity, since LT-related factors can add to the burden of classical risk factors. The aim…
2019 American Transplant Congress
Graft Survival of Fourth Time Renal Transplant Recipients Are Similar to Third Time Transplants: A SRTR Database Analysis
B. Petrun, R. Nygaard, M. Hill, C. Richardson, A. Israni, P. Stahler
Hennepin County Medical Center, Minneapolis, MN
*Purpose: The number of candidates for repeat kidney transplant in the United States has steadily increased over the last 30 years. Second and third kidney…
2019 American Transplant Congress
Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis
L. A. Mendez Castaner
Transplant, Miami Transplant Institute-University of Miami, Miami, FL
*Purpose: Recurrence of focal segmental glomerulosclerosis (FSGS) has been reported between 20-80% with up to 60% of graft loss. Rituximab has demonstrated to be effective…
2019 American Transplant Congress
Similar Quality in Chronic Kidney Disease Multidisciplinary Follow-Up between Kidney Transplant and Pre-Dialysis Patients
M. Carminatti, N. M. Fernandes, F. A. Colugnati, H. Sanders-Pinheiro
Nephrology, UFJF, Juiz de Fora, Brazil
*Purpose: Multidisciplinary clinics are the best approach for pre-dialysis patients (PDP), but few studies depict its impact in kidney transplant recipients (KTR), mostly through comparisons…
2019 American Transplant Congress
The Incidence of Fungal Infections in Pancreas Transplant Recipients in the Absence of Systemic Antifungal Prophylaxis
S. Shaikh¹, M. Cooper¹, A. Nolan¹, P. Abrams²
¹MedStar Georgetown University Hospital, Washington, DC, ²MedStar Gerogetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Fungal infections after pancreas transplantation have been associated with morbidity and mortality, therefore transplant centers may elect to use systemic perioperative antifungal prophylaxis (ppx).…
2019 American Transplant Congress
Identification and Determinants of Cardiac Allograft Vasculopathy Trajectories after Heart Transplantation
G. Bonnet¹, G. Coutance¹, M. Racape¹, M. Raynaud¹, J. Van keer², M. Bories¹, S. Varnous³, P. Rouvier³, R. Guillemain⁴, L. Lecuyer⁴, P. Bruneval⁴, J. Duong-Van-Huyen¹, J. Taupin⁵, M. Naesens², C. Lefaucheur¹, X. Jouven¹, A. Loupy¹
¹Paris Transplant Group, Paris, France, ²KU Leuven, Leuven, France, ³Pitie Salpetriere Hospital, Paris, France, ⁴Georges Pompidou Hospital, Paris, France, ⁵Saint Louis Hospital, Paris, France
*Purpose: CAV is a major contributor of heart transplant recipient’s mortality. However, little is known about CAV long-term evolution profiles and their determinants. Such information…
2019 American Transplant Congress
Post-Liver Transplant Atrial Fibrillation is Associated with Markedly Reduced Short- and Long-Term Patient Survival
R. Rachwan¹, I. Kutkut¹, T. J. Hathaway², L. R. Timsina², M. S. Ghabril³, M. A. Lacerda³, C. A. Kubal², P. D. Bourdillon⁴, R. S. Mangus²
¹Medicine, Indiana University School of Medicine, Indianapolis, IN, ²Surgery, Indiana University School of Medicine, Indianapolis, IN, ³Gastroenterology/Hepatology, Indiana University School of Medicine, Indianapolis, IN, ⁴Cardiology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Postoperative atrial fibrillation (POAF) is the most common perioperative cardiac arrhythmia. Data regarding POAF following liver transplant (LT) is scarce. In the immediate post-LT…
2019 American Transplant Congress
Early Conversion to Belatacept in High Risk Renal Transplant Recipients
A. Santeusanio, A. Bhansali, R. Shapiro, V. Delaney, S. Florman, G. De Boccardo
Mount Sinai Hospital, New York, NY
*Purpose: This study describes our experience with early conversion to belatacept therapy in a diverse patient population including patients with donor specific antibodies (DSA). The…